These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

868 related items for PubMed ID: 28541634

  • 21. Prospective evaluation of qualitative and quantitative ¹⁸F-FDG PET-CT parameters for predicting survival in recurrent carcinoma of the cervix.
    Maharjan S, Sharma P, Patel CD, Sharma DN, Dhull VS, Jain SK, Thulkar S, Malhotra A, Kumar R.
    Nucl Med Commun; 2013 Aug; 34(8):741-8. PubMed ID: 23676840
    [Abstract] [Full Text] [Related]

  • 22. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
    Kim JW, Oh JS, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY.
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
    [Abstract] [Full Text] [Related]

  • 23. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
    Hyun SH, Choi JY, Kim K, Kim J, Shim YM, Um SW, Kim H, Lee KH, Kim BT.
    Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069
    [Abstract] [Full Text] [Related]

  • 24. Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas.
    Roh JL, Kim JS, Kang BC, Cho KJ, Lee SW, Kim SB, Choi SH, Nam SY, Kim SY.
    J Surg Oncol; 2014 Dec; 110(7):869-75. PubMed ID: 25088392
    [Abstract] [Full Text] [Related]

  • 25. (18F)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy.
    Scher N, Castelli J, Depeursinge A, Bourhis J, Prior JO, Herrera FG, Ozsahin M.
    Cancer Radiother; 2018 May; 22(3):229-235. PubMed ID: 29650390
    [Abstract] [Full Text] [Related]

  • 26. Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer.
    Hong JH, Min KJ, Lee JK, So KA, Jung US, Kim S, Eo JS.
    Medicine (Baltimore); 2016 Mar; 95(9):e2992. PubMed ID: 26945420
    [Abstract] [Full Text] [Related]

  • 27. Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma.
    Zhou M, Chen Y, Huang H, Zhou X, Liu J, Huang G.
    Oncotarget; 2016 Dec 13; 7(50):83544-83553. PubMed ID: 27835875
    [Abstract] [Full Text] [Related]

  • 28. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients With Renal Cell Carcinoma.
    Nakajima R, Matsuo Y, Kondo T, Abe K, Sakai S.
    Clin Nucl Med; 2017 Apr 13; 42(4):e177-e182. PubMed ID: 28134692
    [Abstract] [Full Text] [Related]

  • 29. Prognostic value of total lesion glycolysis measured by 18F-FDG PET/CT in patients with locally advanced cervical cancer.
    Hong JH, Jung US, Min KJ, Lee JK, Kim S, Eo JS.
    Nucl Med Commun; 2016 Aug 13; 37(8):843-8. PubMed ID: 27058362
    [Abstract] [Full Text] [Related]

  • 30. Prognostic value of 18 F-FDG PET/CT parameters in patients who undergo salvage treatments for recurrent squamous cell carcinoma of the larynx and hypopharynx.
    Lee JR, Almuhaimid TM, Roh JL, Oh JS, Kim SJ, Kim JS, Choi SH, Nam SY, Kim SY.
    J Surg Oncol; 2018 Sep 13; 118(4):644-650. PubMed ID: 30132891
    [Abstract] [Full Text] [Related]

  • 31. Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
    Satoh K, Patel D, Dieckmann W, Nilubol N, Kebebew E.
    Ann Surg Oncol; 2015 Dec 13; 22 Suppl 3():S714-20. PubMed ID: 26282908
    [Abstract] [Full Text] [Related]

  • 32. Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer.
    Chung HH, Kim JW, Han KH, Eo JS, Kang KW, Park NH, Song YS, Chung JK, Kang SB.
    Gynecol Oncol; 2011 Feb 13; 120(2):270-4. PubMed ID: 21109300
    [Abstract] [Full Text] [Related]

  • 33. Prediction of Recurrence and Mortality of Locally Advanced Esophageal Cancer Patients Using Pretreatment F-18 FDG PET/CT Parameters: Intratumoral Heterogeneity, SUV, and Volumetric Parameters.
    Chang S, Kim SJ.
    Cancer Biother Radiopharm; 2016 Feb 13; 31(1):1-6. PubMed ID: 26844846
    [Abstract] [Full Text] [Related]

  • 34. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
    Husby JA, Reitan BC, Biermann M, Trovik J, Bjørge L, Magnussen IJ, Salvesen ØO, Salvesen HB, Haldorsen IS.
    J Nucl Med; 2015 Aug 13; 56(8):1191-8. PubMed ID: 26045311
    [Abstract] [Full Text] [Related]

  • 35. 18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer.
    Crivellaro C, Signorelli M, Guerra L, De Ponti E, Buda A, Dolci C, Pirovano C, Todde S, Fruscio R, Messa C.
    Gynecol Oncol; 2012 Oct 13; 127(1):131-5. PubMed ID: 22772064
    [Abstract] [Full Text] [Related]

  • 36. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients With Very Early and Early Hepatocellular Carcinoma.
    Hwang SH, Lee JW, Cho HJ, Kim KS, Choi GH, Yun M.
    Clin Nucl Med; 2017 Jan 13; 42(1):34-39. PubMed ID: 27775949
    [Abstract] [Full Text] [Related]

  • 37. Whole-Body Metabolic Tumor Volume, as Determined by (18)F-FDG PET/CT, as a Prognostic Factor of Outcome for Patients With Breast Cancer Who Have Distant Metastasis.
    Son SH, Lee SW, Jeong SY, Song BI, Chae YS, Ahn BC, Lee J.
    AJR Am J Roentgenol; 2015 Oct 13; 205(4):878-85. PubMed ID: 26204115
    [Abstract] [Full Text] [Related]

  • 38. Total Lesion Glycolysis Using ¹⁸F-FDG PET/CT as a Prognostic Factor for Locally Advanced Esophageal Cancer.
    Hong JH, Kim HH, Han EJ, Byun JH, Jang HS, Choi EK, Kang JH, Yoo IeR.
    J Korean Med Sci; 2016 Jan 13; 31(1):39-46. PubMed ID: 26770036
    [Abstract] [Full Text] [Related]

  • 39. FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma.
    Chung HW, Lee KY, Kim HJ, Kim WS, So Y.
    J Cancer Res Clin Oncol; 2014 Jan 13; 140(1):89-98. PubMed ID: 24194352
    [Abstract] [Full Text] [Related]

  • 40. Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer.
    Kim K, Kim SJ, Kim IJ, Kim YS, Pak K, Kim H.
    Nucl Med Commun; 2012 Jun 13; 33(6):613-20. PubMed ID: 22407127
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.